chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Febrile- T 100.5 (R) 1-13-11. Fussy. Elevated WBC -> 1-13-11. 1-14-11 Normal WBC & afebrile. Rechecked pt. 1-13-11 pm & 1-14-11.
The feeling in her arm comes and goes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLU taken for immunisation, administration date Sep2021. Vaccination history included: Bnt162b2 (Dose 1, Transferring agent states that the caller has received three doses of the Pfizer Covid 19 Vaccine), administration date: Jan2021, for covid-19 immunization; Bnt162b2 (Dose 2, Transferring agent states that the caller has received three doses of the Pfizer Covid 19 Vaccine), administration date: Feb2021, for Covid-19 Immunization. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "not recovered", described as "The feeling in her arm comes and goes".  Additional information: The patient had received the first dose in Jan2021, the second dose in Feb2021, and the booster dose in Oct2021. The patient stated that her and her husband received their annual flu vaccines in Sep2021. The patient also stated that she had all of her vaccines in the same arm and her arm has been bothering her ever since. It bothers her when she moves it up and down. The symptom comes and goes, but is still occurring. Patient stated that her husband rotated sites for his injections and he is not having this problem like she is. Follow-up attempts completed. No further information is expected.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I woke up and had a lot of pain. I was having a hard time walking. I went to the doctor, and they ran some labs, and they told me that I needed to see a Rheumatologist. I went to the Rheumatologist, and they did more blood work, and they prescribed some steroids. When I went back, they prescribed Hydroxychloroquine and more steroids. I was also taking Tylenol and Ibuprofen, but it really wasn't working.
3 days after receiving my 1st dose of the Pfizer Covid vaccine,  I woke up with a numb, cold, weak left arm.  No soreness in that arm prior to this event. I had a fine tremor on extension of my left arm. Symptoms resolved after 45 minutes , but returned within a half hour and repeated. I called my doctor and spoke to the advice nurse. I was adviced to go  to the ER within one hour. Instead a did some deep breathing and relaxation and my symptoms resolved and have not returned. I spoke to a doctor and agreed to go to the ER if they returned and also discussed the symptoms with my primary doctor during a video visit and she adviced daily baby ASA.
The client was very anxious before the injections.  She was seated on the exam table.  Immediately after the injections, she stated she felt dizzy and she became pale.  She had an episode of syncope.  She reclined on the exam table and was awake/alert within minutes.  No injuries.
At the administration site in my left deltoid my muscle feels numb/weak. Having difficulty with pain, range of motion and lifting anything including the weight of my arm.
Itchy,  red rash  and swelling around vaccinated area.  Occured seven days  ( 2/22/21) after vaccination. Area warm.  Treating  with ice pack to control the itchiness.
Lips feeling numb; both lips started to swell and got red; red upper lip; Upper lip dry; Rash; A spontaneous report was received from physician a concerning a 44-year-old, female patient who received Moderna's COVID-19 vaccine and developed a rash, numb, swollen, red, and dry lips.  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included women's multi-vitamins.  On 30 Dec 2020, approximately 12:30pm prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 025L2A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.     On 30 Dec 2020, after receiving the vaccine, the patient developed a rash. The next day on 01 Jan 2021, her upper lip was dry and both lips started to swell. On 02 Jan 2021, the patient started to feel better, however, her lips were still swollen. The patient stated her upper lip was red and has not improved. As of 04 Jan 2020, the patient's upper lip felt numb. Treatment for the event included diphenhydramine and lip balm.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The outcome for the event, of a rash, was considered recovered on 30 Dec 2020. The event, of the dry upper lip, was considered resolved on 01 Jan 2021. The outcome of the events swollen, red and numb lips, was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Roughly 12 hours after the vaccine, side effects began. Started with worsened insomnia, chills, nausea, and the usual vaccine site soreness. Has grown within roughly 8 hours to include these symptoms: fatigue, dizziness, soreness, excessive thirst, headache.
after I had the shots I had some chest discomfort; This spontaneous case was reported by an other health care professional and describes the occurrence of CHEST DISCOMFORT (after I had the shots I had some chest discomfort) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (after I had the shots I had some chest discomfort). At the time of the report, CHEST DISCOMFORT (after I had the shots I had some chest discomfort) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  It was reported that the patient received the first Moderna shot in Dec and the second one in Jan. The patient having the shots had some chest discomfort. The patient didn't receive the booster dose and it has been 11 month span since last shot.  No treatment information was provided.
whole face started to tingle; had two more episodes of whole face tingling, mild but still not completely gone; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6027) via an unspecified route of administration in the right arm on 27Mar2021 at 10:45 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included heart murmur. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), sumatriptan (IMITREX), fish oil (MANUFACTURER UNKNOWN) and acetylsalicylic acid; caffeine; paracetamol (EXCEDRIN) and multivitamins (MANUFACTURER UNKNOWN); all for unspecified indication from unknown date. The patient previously took tetracycline (MANUFACTURER UNKNOWN) and morphine (MANUFACTURER UNKNOWN) and experienced drug allergy to both. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 11:15 (approximately after 30 minutes after shot), the patient experienced whole face started to tingle which lasted for 45 minutes and patient felt fine after that. On 31Mar2021, the patient had two more episodes of whole face tingling, one lasted about an hour, the next was severe and lasted for about four hours and had become mild (at the time of reporting) but still not completely gone away after 24 hours. The event resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of face started to tingle and included monitoring of blood pressure and heart rate (unknown results). The patient had blood pressure and heart rate measurements on an unknown date and the results were unknown. The clinical outcome of the event tingling was recovered with sequalae with the date 27Mar2021.   No follow-up attempts are needed. No further information is expected.
Had severe pain in lower intestine. Pain similar to labor pains. Difficulty evacuating.  Lasted 30 minutes or more. BM  was solid at first then watery.
Developed 4 week course of purpuric rash of HSP, polyarthralgia, abd pain and vomiting.
rash began 6days ago w/fever of 102-102.5;maculo-papular rash began on face & spread to entire body;vomiting & diarrhea last 2-3 days
ADMINISTERED 2.5ML OF VACCINE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 21-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 21-MAY-2021, the subject experienced administered 2.5ml of vaccine. The action taken with covid-19 vaccine  was not applicable. The outcome of administered 2.5ml of vaccine was not reported. This report was non-serious.
His arm became swollen to tennis ball size off center from injection site. It was warm and hard to the touch about an inch below the injection site
vaccination site rash; vaccination site erythema; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (vaccination site rash) and VACCINATION SITE ERYTHEMA (vaccination site erythema) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (vaccination site rash) and VACCINATION SITE ERYTHEMA (vaccination site erythema). At the time of the report, VACCINATION SITE RASH (vaccination site rash) and VACCINATION SITE ERYTHEMA (vaccination site erythema) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was given. No treatment information was given.
Ok for about 12 hours after inoculation, Feb.10, then chills, fever, severe body aches and fatigue.  Symptoms continued well into the following day, Feb. 11.  Chills and fever subsided, late evening,  while body aches remained.  Treated with fluids, and two doses of Ibuprofen, 600 mg.  11::00 am and 8pm on the 11th.  Slept solidly that night and awoke feeling refreshed, free of all symptoms.
Nurse administered too much vaccine.  Contacted.  Only symptom was fever.  Advised mother to notify clinic  if any significantly worsening symptoms.
Chills; Fever 101°F; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever 101°F) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever 101°F) and HEADACHE (Headache). At the time of the report, CHILLS (Chills), PYREXIA (Fever 101°F) and HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 101 f 101 f.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information was not provided. Treatment information was not provided.   Reporter did not allow further contact
PATIENT REPORTED FEELING TINGLING SENSATION ON BILATERAL LOWER ARMS AFTER WITHIN 10 MINUTES OF VACCINATION. PATIENT ALSO REPORTED SKIN BLOTCHING ON BILATERAL LOWER ARMS WITHIN 10 MINUTES OF VACCINATION, BUT WAS UNCONFIRMED ON VISUAL INSPECTION BY PHARMACIST. PATIENT REPORTED NO OTHER SYMPTOMS.  PATIENT REPORTED FEELING SIMILAR TINGLING AFTER FIRST DOSE WHICH WORSENED WITH COUGH.  PATIENT WAS CONCERNED THAT THIS MAY BE ALLERGY TO VACCINATION OR ANXIETY RELATED TO VACCINE ADMINISTRATION.  PATIENT WAS OBSERVED BY PHARMACIST FOR 30 MINUTES FOLLOWING ADMINISTRATION OF SECOND DOSE MODERNA COVID 19 VACCINE WITH PATIENT REPORTED REVERSAL OF SKIN BLOTCHING BUT NOT CHANGE IN TINGLING SENSATION IN BILATERAL ARMS. PATIENT ADVISED TO SEEK MEDICAL ATTENTION.
product storage error; No adverse event; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions and allergies were unknown. Concomitant therapies included sterile diluent (lot # N031941, expiration date 03-AUG-2020). On 27-FEB-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) with lot # S013715, expiration date 01-NOV-2020 (dose, frequency, anatomical location were unknown) via unspecified route for prophylaxis. The measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant human albumin (rHA) (PROQUAD) was reconstituted with properly stored sterile diluent at a temperature of 6 degrees Fahrenheit to 14 degrees Fahrenheit or minus 14 degree Celsius to minus 10 degree Celsius at minus 12.1 degree Celsius for a time frame of 4 hours. There was a previous temperature excursion. The temperature of 6 degrees Fahrenheit to 14 degrees Fahrenheit or minus 14 degree Celsius to minus 10 degree Celsius at minus 12.1 degree Celsius for a time frame of 6 hours 30 minutes. Digital data logger was involved. No adverse effects were reported. Product quality complaint (PQC) was not involved.
Patient received the Janssen vaccine on 7/21/21 so was fully vaccinated when they tested positive for COVID-19 on 9/15/21
No additional adverse effects reported; Multiple unspecified patients were administered improperly stored vaccines; This spontaneous report has been received from a nurse concerning multiple numbers of patients of unknown age and gender. Their past drug and medical history, drug allergies or reactions, as well as their concomitant medications, were not provided.   From 20-FEB-2020 to 08-JUL-2020, the patients were vaccinated with improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (recombinant Human albumin (rHA) (PROQUAD) (lot numbers T005406, expiry date 12-AUG-2021,  S027463, expiry date 02-MAR-2021, S012532, expiry date 20-OCT-2020 and T003833, expiry date 01-AUG-2021 have been verified to be valid lot numbers) and with varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number S036636, expiry date 14-NOV-2021 and S022756, expiry date 22-JUL-2020 (reported as 22-JUN-2021) as prophylaxis (concentration, dose, dose description, frequency of vaccination scheme and route and anatomical location of vaccination were not reported) ( product storage error). The vaccines were reconstituted with properly stored sterile diluent.   The Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) and varicella virus vaccine live (Oka/Merck) (VARIVAX) underwent temperature excursions between -14 to -10 degrees Celsius (-10.1 degrees Celsius) for 4 hours and 15 minutes, and from -9 to 8 degrees Celsius (-7.2 degrees Celsius) for 2 hours and 27 minutes, as recorded by a data logger. There were no other previous temperature excursions.   No adverse effects were reported for the patients.  This is a non-valid case due to a lack of patients' identifiers.
Pt stated her arm was black & blue immediately. She said the RPh had to replace her bandage because she bled so much. 6 days later it was still black & blue the size of a baseball. Her arm was also swollen & red down to 3 inches above her elbow. Finally subsided 12/7/12.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown demographics. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates since 11-FEB-2016, the patients were vaccinated orally with improperly stored doses of ROTATEQ (lot # L002042, expiration date: 28-JUL-2016, lot # L008578, expiration date: 14-DEC-2016 and lot # reported as M014318, expiration date: 30-SEP-2017; dose was not provided). The vaccine underwent a temperature excursion in range between 30 degrees Fahrenheit and 53.2 degrees Fahrenheit for undetermined amount of time, which was detected by a data logger. There was no previous temperature excursion. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
He went and got vaccinated / its so very,very painful; This case was reported by a consumer via  interactive digital media and described the occurrence of pain in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's wife who reported for her husband. The age at vaccination not reported. The patient got vaccinated and experienced pain and mentioned to be careful.
This spontaneous report was received from a registered nurse referring to a female patient of unknown age and gender. Concurrent conditions and medical history were not reported. On 03-DEC-2015, patient was vaccinated with M-M-R II (strength, dose and route were not provided) lot # L011528 and expiration date 03-APR-2017, that were improperly storage. No concomitant medications was reported. Symptoms were reported. No product quality complain was involved. Additional information has been requested.
Mom called stating after getting shots (1/17/07) that child had fever on 1/18/07. On 1/18/07 patient saw dr office who states fever of 101.3. Right was 2 hours to immunizations and constipation and no contrainchartion for future immunizations.
Rash and Hives mostly on the injected arm and other parts of body. Day 6 rash continues to bloom and hives now on buttocks, Using Topical BENADRYL. She went to Urgent care, Documented erythematous, blanching raised wheals to bilateral axilla left more than right lesions noted below both breasts and anterior thighs. Declined Prescription Prednisone OTC antihistamines.
4 y/o female with (L) upper anterior thigh w/ superficial erythema and mild induration x4 days.
Started noticing chicken pox lesions on Monday 5/22/06 arm chest, and back.
During 15 minute observation period following vaccination. Patient came to report slightly blurred vision in left eye and asked if that is a common side effect. Pharmacist looked up in computer and saw eye discomfort listed under adverse effects. Offered to call the manufacturer to obtain more detailed info but patient stated it was improving and did not want to wait around. RPh told her that if things worsened to contact MD right away.
WIDESPREAD CUTANEOUS REACTION; This spontaneous report received from a consumer via a company representative concerned an 80 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced widespread cutaneous reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of widespread cutaneous reaction was not reported. This report was non-serious.
Purpura on legs that started 2 days after flu vaccine that is still present on 11-2-10. Labs (CBC) are being done on 11-2-10 and a follow up visit on 11-16-10.
Second shot botched, vaccine ran down arm; Vaccine ran down arm to elbow; Vaccine ran down arm to elbow; This case was reported by a consumer via interactive digital media and described the occurrence of accidental underdose in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced accidental underdose, inadvertent exposure to vaccine and exposure via skin contact. On an unknown date, the outcome of the accidental underdose, inadvertent exposure to vaccine and exposure via skin contact were unknown.     Additional Information: GSK Receipt Date: 06-AUG-2022 Reporter's Comments:  This case was reported by consumer (patient) via interactive digital media. The patient had second shot of shingrix was botched as the needle became loose from the syringe and some of the vaccine ran down to patient's arm to elbow.  The pharmacist suggested to patient to get a third shot in 2-6 months.  The patient had no idea how much vaccine got into the arm. Additional Supportive Information: While administrating the 2nd shot of the Shingrix vaccine to a patient some of the vaccine ran down to patient's arm to elbow, but no idea how much vaccine got into the arm, which led to accidental underdose, exposure via skin contact and inadvertent exposure to vaccine.
Patient Given 0.7ml high dose flu shot instead of 0.5 Ml regular dose. Pt notified.
Information has been received from a consumer concerning his 72 year old wife with diabetes and a history of several strokes, no drug reactions/allergies who was vaccinated on 15-JUN-2010, with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot#: not reported) on her right arm. Concomitant therapy included ascorbic acid and "vitamin C", pyridoxine "B6", "3 blood pressure medicines", "fluid pills" and "heart rhythm pill". On 17-JUN-2010, the patient started feeling pain (specific area not provided), noticed a rash on both of her arms, and swelled knees. On 19-JUN-2010, the patient's husband took her to the emergency room where an x-ray was taken on the knees and there were no broken bones. Consumer took patient to her doctor on 22-JUN-2010, who prescribed "pain medication and a cream" (names and manufacturers were unspecified for either medication). Consumer also reported that the knee swelling worsened on 23-JUN-2010. At the time of the report, the rash was "not as bad as it was before" after using the "cream" that the doctor prescribed. Pain a swelled knees persisted. Additional information has been requested.
While pt was leaving the office, pt fainted and fell back into the wall, hitting her head. Within a minute, pt came to/alert but distraught. Pt described seeing black stops and dizziness before fainting episode.